Back to GetFilings.com



 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

FORM 10-Q

 

ý

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934

 

 

 

 

 

For the quarterly period ended March 31, 2005

 

 

 

OR

 

 

 

o

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934

 

 

 

 

 

For the transition period from                 to

 

Commission file number 0-27444

 


 

SOURCECORP, INCORPORATED

(Exact name of registrant as specified in its charter)

 

DELAWARE

 

75-2560895

(State or other jurisdiction of incorporation or organization)

 

(I.R.S. Employer Identification No.)

 

 

 

3232 MCKINNEY AVENUE, SUITE 1000
DALLAS, TEXAS

 

75204

(Address of principal executive offices)

 

(Zip code)

 

 

 

REGISTRANT’S TELEPHONE NUMBER, INCLUDING AREA CODE: (214) 740-6500

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  ý  No  o

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Exchange Act Rule 12b-2). Yes  ý  No  o

 

As of April 29, 2005, 15,670,116 shares of the registrant’s Common Stock, $.01 par value per share, were outstanding.

 

 



 

SOURCECORP, INCORPORATED AND SUBSIDIARIES

FORM 10-Q FOR THE PERIOD ENDED MARCH 31, 2005

 

INDEX

 

PART I. FINANCIAL INFORMATION

 

 

 

 

Item 1

Financial Statements

 

 

 

 

 

Condensed Consolidated Balance Sheets — December 31, 2004 and March 31, 2005 (unaudited)

 

 

 

 

 

Condensed Consolidated Statements of Operations — Three months ended March 31, 2004 and 2005 (unaudited)

 

 

 

 

 

Condensed Consolidated Statements of Cash Flows — Three months ended March 31, 2004 and 2005 (unaudited)

 

 

 

 

 

Notes to Condensed Consolidated Financial Statements (unaudited)

 

 

 

 

Item 2

Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

 

 

 

Item 3

Quantitative and Qualitative Disclosures about Market Risk

 

 

 

 

Item 4

Controls and Procedures

 

 

 

 

PART II. OTHER INFORMATION

 

 

 

 

Item 1

Legal Proceedings

 

 

 

 

Item 2

Unregistered Sales of Equity Securities and Use of Proceeds

 

 

 

 

Item 6

Exhibits

 

 

 

 

 

SIGNATURES

 

 

 

 

 

Index to Exhibits

 

 

2



 

PART I. FINANCIAL INFORMATION

 

Item 1.      Financial Statements

 

SOURCECORP, INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(IN THOUSANDS, EXCEPT SHARE DATA)

 

 

 

December 31,
2004

 

March 31,
2005

 

 

 

(Unaudited)

 

ASSETS

 

 

 

 

 

CURRENT ASSETS:

 

 

 

 

 

Cash and cash equivalents

 

$

3,722

 

$

244

 

Accounts and notes receivable, less allowance for doubtful accounts of $9,331 and $8,800, respectively

 

65,315

 

73,885

 

Inventories

 

875

 

1,064

 

Deferred income taxes

 

5,272

 

5,785

 

Income tax receivable

 

5,077

 

 

Prepaid expenses and other current assets

 

6,142

 

7,285

 

Assets of discontinued operations

 

842

 

 

Total current assets

 

87,245

 

88,263

 

PROPERTY, PLANT AND EQUIPMENT, net of accumulated depreciation of $45,166 and $48,409, respectively

 

39,603

 

41,866

 

GOODWILL

 

326,139

 

325,185

 

INTANGIBLES, net of amortization of $1,700 and $1,906, respectively

 

4,904

 

4,698

 

OTHER NONCURRENT ASSETS

 

11,524

 

11,225

 

Total assets

 

$

469,415

 

$

471,237

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

CURRENT LIABILITIES:

 

 

 

 

 

Accounts payable and accrued liabilities

 

$

52,549

 

$

44,954

 

Current maturities of long-term obligations

 

258

 

234

 

Income tax payable

 

 

1,371

 

Liabilities of discontinued operations

 

326

 

 

Total current liabilities

 

53,133

 

46,559

 

LONG-TERM OBLIGATIONS, net of current maturities

 

87,547

 

94,225

 

DEFERRED INCOME TAXES

 

13,210

 

11,823

 

LONG-TERM CUSTOMER LIABILITY

 

4,147

 

1,305

 

DEFERRED REVENUE

 

8,010

 

6,721

 

OTHER LONG-TERM OBLIGATIONS

 

10,947

 

10,418

 

Total liabilities

 

176,994

 

171,051

 

COMMITMENTS AND CONTINGENCIES

 

 

 

 

 

STOCKHOLDERS’ EQUITY:

 

 

 

 

 

Preferred stock, $.01 par value, 1,000,000 shares authorized, no shares issued or outstanding

 

 

 

Common stock, $.01 par value, 26,000,000 shares authorized, 15,703,586 and 15,706,786 shares issued and 15,666,916 and 15,670,116 shares outstanding at December 31, 2004 and March 31, 2005, respectively

 

157

 

157

 

Additional paid-in-capital

 

193,925

 

193,925

 

Retained earnings

 

103,136

 

110,270

 

 

 

297,218

 

304,352

 

Less—

Treasury stock, at cost, 36,670 shares

 

(501

)

(501

)

Less—

Deferred compensation

 

(4,296

)

(3,665

)

Total stockholders’ equity

 

292,421

 

300,186

 

Total liabilities and stockholders’ equity

 

$

469,415

 

$

471,237

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

3



 

SOURCECORP, INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(IN THOUSANDS, EXCEPT PER SHARE DATA)

 

 

 

Three Months Ended
March 31,

 

 

 

2004

 

2005

 

 

 

(Unaudited)

 

REVENUE

 

$

95,816

 

$

105,932

 

COST OF SERVICES EXCLUSIVE OF DEPRECIATION

 

56,393

 

58,536

 

DEPRECIATION

 

3,200

 

3,423

 

Gross profit

 

36,223

 

43,973

 

SELLING, GENERAL AND ADMINISTRATIVE EXPENSES

 

31,068

 

30,221

 

AMORTIZATION

 

89

 

206

 

Operating income

 

5,066

 

13,546

 

OTHER (INCOME) EXPENSE:

 

 

 

 

 

Interest expense

 

660

 

1,211

 

Interest income

 

(4

)

(45

)

Other (income) expense, net

 

119

 

315

 

Income from continuing operations before income taxes

 

4,291

 

12,065

 

PROVISION FOR INCOME TAXES

 

1,716

 

4,710

 

INCOME FROM CONTINUING OPERATIONS

 

2,575

 

7,355

 

INCOME (LOSS) FROM DISCONTINUED OPERATIONS, NET OF TAX

 

(510

)

(221

)

NET INCOME

 

$

2,065

 

$

7,134

 

NET INCOME PER COMMON SHARE

 

 

 

 

 

BASIC

 

 

 

 

 

Continuing Operations

 

$

0.16

 

$

0.47

 

Discontinued Operations

 

(0.03

)

(0.01

)

Total

 

$

0.13

 

$

0.46

 

DILUTED

 

 

 

 

 

Continuing Operations

 

$

0.16

 

$

0.46

 

Discontinued Operations

 

(0.03

)

(0.01

)

Total

 

$

0.13

 

$

0.45

 

WEIGHTED AVERAGE COMMON SHARES OUTSTANDING

 

 

 

 

 

BASIC

 

16,096

 

15,670

 

DILUTED

 

16,448

 

15,963

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

4



 

SOURCECORP, INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(IN THOUSANDS)

 

 

 

Three Months Ended
March 31,

 

 

 

2004

 

2005

 

 

 

(Undaudited)

 

CASH FLOWS FROM OPERATING ACTIVITIES:

 

 

 

 

 

Income from continuing operations

 

$

2,575

 

$

7,355

 

Adjustments to reconcile income to net cash provided by (used in) operating activities:

 

 

 

 

 

Depreciation and amortization

 

3,289

 

3,629

 

Deferred income tax provision (benefit)

 

1,424

 

(1,900

)

Compensation expense on restricted stock grants

 

528

 

631

 

Loss on sale of property, plant and equipment

 

 

15

 

Change in operating assets and liabilities:

 

 

 

 

 

Accounts and notes receivable

 

(2,523

)

(8,303

)

Inventories, prepaid expenses and other assets

 

(498

)

(1,441

)

Accounts payable and accrued liabilities

 

(4,650

)

(4,435

)

Net cash provided by (used in) operating activities from continuing operations

 

145

 

(4,449

)

Net cash provided by (used in) operating activities from discontinued operations

 

565

 

(171

)

Net cash provided by (used in) operating activities

 

710

 

(4,620

)

CASH FLOWS FROM INVESTING ACTIVITIES:

 

 

 

 

 

Net proceeds received from divestitures

 

 

224

 

Purchase of property, plant and equipment

 

(3,307

)

(5,705

)

Proceeds from disposition of property, plant and equipment

 

9

 

3

 

Cash paid for acquisitions, net of cash acquired

 

(400

)

(34

)

Net cash used in investing activities from continuing operations

 

(3,698

)

(5,512

)

Net cash used in investing activities from discontinued operations

 

(100

)

 

Net cash used in investing activities

 

(3,798

)

(5,512

)

CASH FLOWS FROM FINANCING ACTIVITIES:

 

 

 

 

 

Proceeds from exercise of common stock options

 

94

 

 

Proceeds from long-term obligations

 

92,745

 

52,975

 

Principal payments on long-term obligations

 

(87,693

)

(46,321

)

Net cash provided by financing activities from continuing operations

 

5,146

 

6,654

 

 

 

 

 

 

 

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

 

2,058

 

(3,478

)

CASH AND CASH EQUIVALENTS, beginning of period

 

2,097

 

3,722

 

CASH AND CASH EQUIVALENTS, end of period

 

$

4,155

 

$

244

 

SUPPLEMENTAL DATA:

 

 

 

 

 

Cash paid for:

 

 

 

 

 

Income taxes, net of income tax refunds

 

$

53

 

$

11

 

Interest

 

$

629

 

$

1,209

 

NONCASH FINANCING TRANSACTIONS:

 

 

 

 

 

Assets acquired through financing and capital lease arrangements

 

$

151

 

$

 

Restricted stock grant (132,000 and 0 shares, respectively)

 

$

3,454

 

$

 

Common stock accrued related to business acquisitions (9,623 and 0 shares, respectively)

 

$

261

 

$

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

5



 

SOURCECORP, INCORPORATED AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

1. Basis of Presentation

 

The accompanying condensed consolidated financial statements and related notes to the condensed consolidated financial statements include the accounts of SOURCECORP, Incorporated and subsidiaries (collectively, the “Company”).  All significant intercompany accounts and transactions have been eliminated in consolidation. These condensed consolidated financial statements have been prepared by the Company, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the “Commission”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations. However, the Company believes that all disclosures are adequate to make the information presented not misleading.  These condensed consolidated financial statements should be read in conjunction with the Company’s consolidated financial statements and the related notes thereto in the Annual Report on Form 10-K filed with the Commission on March 31, 2005.

 

In the opinion of management, all adjustments necessary to fairly present the Company’s financial position at March 31, 2005, and results of operations and cash flows for the three months ended March 31, 2005 and 2004 have been included. The results of operations for the three months ended March 31, 2005 are not necessarily indicative of the results to be expected for the full fiscal year or for any future periods.

 

The Company uses estimates and assumptions required for preparation of the financial statements. The estimates are primarily based on historical experience and business knowledge and are revised as circumstances change. However, actual results could differ from the estimates.

 

2. Reserves and Other Loss Contingencies

 

Self-Insurance Liabilities and Reserves.  The Company is self-insured for workmen’s compensation liabilities and a significant portion of its employee medical costs. The Company accounts for its self-insurance programs based on actuarial estimates of the amount of loss inherent in that period’s claims, including losses for which claims have not been reported. These loss estimates rely on actuarial observations of ultimate loss experience for similar historical events. The Company limits its risk by carrying stop-loss policies for significant claims incurred for both workmen’s compensation liabilities and medical costs. The Company’s exposure under the stop-loss policies for workmen’s compensation and medical costs is limited based on fixed dollar amounts.  For workman’s compensation, the fixed dollar amount of stop-loss coverage is $500,000 per occurrence.  For medical costs, the fixed dollar amount of stop-loss coverage is $100,000 per covered participant for the fiscal plan year, with a lifetime limit of liability per covered participant of $1,900,000.  The Company’s current stop-loss policy for medical costs is to expire on June 30, 2005.  The Company is currently in negotiations to renew or replace the current stop-loss policy upon its expiration.

 

Accrual balances related to workmen’s compensation and medical costs, included in accured liabilities in the Condensed Consolidated Balance Sheets, are as follows (in thousands):

 

 

 

December 31,
2004

 

March 31,
2005

 

Workmen’s Compensation

 

$

2,407

 

$

2,226

 

Employee Medical Insurance

 

2,229

 

2,323

 

Total

 

$

4,636

 

$

4,549

 

 

Other Loss Contingencies.  The Company records liabilities when it is probable that a liability has been incurred and the amount of the loss is reasonably estimable in accordance with Statement of Financial Accounting Standards (“SFAS”) No. 5, Accounting for Contingencies.  Disclosure is required when there is a reasonable possibility that the ultimate loss will exceed the recorded provision. Contingent liabilities are often resolved over long periods of time. Estimating probable losses requires analysis of multiple forecasts that often depend on judgments about potential actions by third parties such as regulators. The Company’s loss contingencies consist primarily of estimates related to the probable outcome of pending litigation.  See Note 7.

 

6



 

3. Stockholders’ Equity and Stock-Based Compensation

 

Stock-Based Compensation

 

In 2002, the Board of Directors and Shareholders of the Company approved the SOURCECORP, Incorporated 2002 Long-Term Incentive Plan (the “2002 Plan”), which replaced the 1995 Stock Option Plan, as amended (the “1995 Plan”). The 2002 Plan authorizes awards of options to purchase common stock and may include incentive stock options (“ISOs”) and/or non-qualified stock options (“NQSOs”), stock appreciation rights, restricted stock, deferred stock, bonus stock and awards in lieu of cash obligations, dividend equivalents and other stock based awards.

 

The Board of Directors has appointed a committee (the “Committee”), which is composed of independent, non-employee directors, to administer the 2002 Plan. Persons eligible to receive awards under the plan include directors, officers, employees of the Company and its subsidiaries, and persons who provide consulting services to the Company deemed by the Committee, or the Board as a whole, to be of substantial value to the Company, persons who have been offered employment by the Company or its subsidiaries, and persons employed by an entity that the Committee reasonably expects to become a subsidiary of the Company. Awards granted under the 2002 Plan may, at the discretion of the Committee, be granted either alone or in addition to, in tandem with or in substitution for any other award granted under the 2002 Plan or any other plan of the Company, any subsidiary or any business entity to be acquired by the Company or one of its subsidiaries. The Committee determines vesting in awards granted under the 2002 Plan.

 

The Company applies Accounting Principles Board Opinion (“APB”) No. 25, Accounting for Stock Issued to Employees, and related interpretations in accounting for stock-based compensation and awards. Stock option and warrant awards are granted at the market price of the common stock on the date of grant. Accordingly, no compensation expense has been recognized for stock options and warrants. Had compensation expense been determined based upon the fair value at grant dates for stock options and warrants consistent with the method of SFAS No. 123, Accounting for Stock-Based Compensation, the Company’s net income and earnings per share would have been as follows (in thousands, except per share data):

 

 

 

Three Months Ended
March 31,

 

 

 

2004

 

2005

 

Net income as reported

 

$

2,065

 

$

7,134

 

Add: Deferred compensation expense included in reported net income, net of related tax effect

 

332

 

385

 

Deduct: Total stock-based employee compensation expense determined under fair value based method for all awards, net of tax effect

 

(908

)

(768

)

Proforma net income

 

$

1,489

 

$

6,751

 

 

 

 

 

 

 

Earnings per share:

 

 

 

 

 

Reported basic earnings per share

 

$

0.13

 

$

0.46

 

Proforma basic earnings per share

 

$

0.09

 

$

0.43

 

 

 

 

 

 

 

Reported diluted earnings per share

 

$

0.13

 

$

0.45

 

Proforma diluted earnings per share

 

$

0.09

 

$

0.42

 

 

The fair value of stock options and warrants was estimated on the date of grant using the Black-Scholes option pricing model using the following assumptions:

 

 

 

Three Months Ended
March 31,

 

 

 

2004

 

2005

 

Weighted-average risk-free interest rate

 

3.1

%

0.0

%

Weighted-average dividend yield

 

0.0

%

0.0

%

Weighted-average volatility

 

41.4

%

0.0

%

Weighted-average expected life

 

4.0 years

 

0.0 years

 

 

On December 18, 2004, the Compensation Committee of the Board of Directors approved, and the Board of Directors ratified, the acceleration of the vesting of certain options and warrants (specifically options and warrants issued in 2002 or earlier, and only those options and warrants that by their terms would not vest before June 30, 2005), provided that the holders were employed by the Company as of December 31, 2004. The action was taken as a method to provide a further incentive to option holders to maximize shareholder value without creating an immediate windfall (as substantially all of such options and warrants had exercise prices above $30 per share). In taking such action, the Compensation Committee and the Board were mindful that the accounting treatment of stock

 

7



 

options and warrants was anticipated to change in the second half of 2005 (which date has changed to the first quarter of 2006), requiring the expensing of unvested stock options and warrants. As such, the Compensation Committee and the Board were mindful that accelerating the vesting of such options and warrants would avoid an expense in future periods that did not provide any direct associated benefit to individuals and that could otherwise negatively impact the Company’s reported results in future periods. This action resulted in the acceleration of vesting of 364,100 stock options and warrants at a weighted-average strike price of $30.38 during the fourth quarter of 2004. Although this action established a new measurement date for the stock options and warrants under the intrinsic value method, there was no compensation expense associated with the vesting acceleration as the strike price related to the accelerated stock options and warrants was above the fair market value of the Company’s common stock on December 17, 2004.  As a result of the acceleration, additional expense of approximately $2.1 million, net of tax, was included in the pro-forma disclosure during the three months ended December 31, 2004 related to the acceleration.

 

During 2003, the Company awarded 164,300 shares of restricted stock under the 2002 Plan. The restricted shares were issued at no cost to the recipients; therefore, the Company recorded deferred compensation of approximately $2.9 million based on the market value of the stock at the date of issuance.  Subsequent to the grant date, certain forfeitures of restricted stock have occurred resulting in a total award of 155,000 shares and total deferred compensation of $2.8 million.  The deferred compensation charge is being amortized to expense over the vesting period of the restricted stock. The restricted shares vest over a three-year period ending July 1, 2006, with acceleration of the vesting period occurring if a certain stock price or performance target is achieved.

 

During the three months ended March 31, 2004, the Company awarded 132,000 shares of restricted stock under the 2002 Plan.  The restricted shares were issued at no cost to the recipients; therefore, the Company recorded deferred compensation of approximately $3.5 million based on the market value of the stock at the date of issuance.  Subsequent to the grant date, certain forfeitures of restricted stock have occurred resulting in a total award of 126,750 shares and total deferred compensation of $3.3 million.  The deferred compensation charge is being amortized to expense over the vesting period of the restricted stock.  The restricted shares vest at the end of a three-year period ending January 10, 2007, with acceleration of the vesting period occurring if certain performance targets are achieved. 

 

During the three months ended June 30, 2004, the Company awarded 50,550 shares of restricted stock under the 2002 Plan.  The restricted shares were issued at no cost to the recipients; therefore, the Company recorded deferred compensation of approximately $1.2 million based on the market value of the stock at the date of issuance.  The deferred compensation charge is being amortized to expense over the vesting period of the restricted stock.  The restricted shares vest on January 10, 2007 and May 26, 2007, with acceleration of the vesting period for certain shares occurring if certain performance targets are achieved.

 

Deferred compensation amortized to expense, included in selling, general and administrative expenses in the Condensed Consolidated Statements of Operations, related to the restricted stock grants discussed above is as follows (in thousands):

 

 

 

Three months ended
March 31,

 

 

 

2004

 

2005

 

May 2003 grant

 

$

252

 

$

238

 

January 2004 grant

 

276

 

276

 

May 2004 grant

 

 

117

 

Total

 

$

528

 

$

631

 

 

Common Stock Repurchase Program

 

During 2003, the Company activated the $30.0 million stock repurchase program authorized by the Board of Directors in April 2001 and purchased 1,306,979 shares of its common stock at a cost of approximately $20.7 million.  During the three months ended June 30, 2004, the Company purchased an additional 361,415 shares of its common stock at a cost of approximately $9.3 million completing the original repurchase program.

 

During the third quarter of 2004, the Board of Directors authorized the purchase of an additional $20.0 million of shares from time to time in the open market as conditions warrant.  During the three months ended September 30, 2004, the Company purchased 34,800 shares of common stock at a cost of approximately $0.8 million.  During the three months ended December 31, 2004, the Company purchased 82,724 shares of common stock at a cost of approximately $1.8 million. 

 

The repurchased shares were recorded in the balance sheet as a reduction to common stock, additional paid-in-capital, and retained earnings.  These shares have been retired and returned to the status of authorized but unissued shares of the Company.

 

No additional shares were purchased during the three months ended March 31, 2005.

 

8



 

Net Income Per Share

 

Basic and diluted net income per common share were computed in accordance with SFAS No. 128, Earnings Per Share. The differences between basic weighted average common shares and diluted weighted average common shares and potentially dilutive common shares are as follows (in thousands):

 

 

 

Three Months Ended
March 31,

 

 

 

2004

 

2005

 

Basic weighted average common shares

 

16,096

 

15,670

 

Weighted average options, warrants and restricted stock

 

328

 

293

 

Other contingent consideration

 

24

 

 

Diluted weighted average common shares

 

16,448

 

15,963

 

 

At March 31, 2004 and 2005, approximately 1.8 million and 3.0 million, respectively, of common shares were not included in the diluted earnings per share calculation because they were anti-dilutive.  These common shares may be dilutive in future earnings per share calculations.

 

4. Discontinued Operations

 

2005 Divestiture

 

During the first quarter of 2005, the Company formally committed to a plan of divestiture for a non-strategic asset group related to its litigation service operations reported in the Healthcare, Regulatory and Legal Compliance segment in prior periods.  During 2004, the operation contributed approximately $3.7 million of revenue and loss before income taxes of approximately $0.3 million.  The Company has concluded the asset group meets the requirements for discontinued operations accounting treatment as outlined in SFAS No. 144, “Accounting for the Impairment or Disposal of Long-Lived Assets” during the quarter ended March 31, 2005.  As such, the operating assets and liabilities of this operation are presented in the condensed consolidated balance sheet as Assets and Liabilities of Discontinued Operations and the results associated with this operation are presented in the condensed consolidated statement of operations as Income (Loss) from Discontinued Operations, net of tax.

 

During the first quarter of 2005, the Company completed the sale of this non strategic asset group, resulting in the recognition of a pre-tax loss of approximately $0.2 million.  In connection with this transaction, the Company received approximately $0.2 million of cash proceeds and a promissory note of approximately $0.1 million.

 

Summarized selected financial information for the 2005 divestiture discussed above is as follows (in thousands):

 

 

 

Three Months Ended
March 31,

 

 

 

2004

 

2005

 

 

 

(Unaudited)

 

REVENUE

 

$

1,060

 

$

260

 

COST OF SERVICES

 

748

 

194

 

DEPRECIATION

 

21

 

6

 

Gross profit

 

291

 

60

 

SELLING, GENERAL AND ADMINISTRATIVE EXPENSES

 

329

 

191

 

Operating loss

 

(38

)

(131

)

OTHER (INCOME) EXPENSE:

 

 

 

 

 

Loss on sale of asset group

 

 

168

 

Loss from discontinued operations before income taxes

 

(38

)

(299

)

PROVISION (BENEFIT) FOR INCOME TAXES

 

(15

)

(117

)

LOSS FROM DISCONTINUED OPERATIONS

 

$

(23

)

$

(182

)

 

9



 

The assets and liabilities of the discontinued operation are stated separately on the Condensed Consolidated Balance Sheets.  The major asset and liability categories are as follows (in thousands):

 

 

 

December 31,
2004

 

 

 

(Unaudited)

 

ASSETS OF DISCONTINUED OPERATION

 

 

 

CURRENT ASSETS:

 

 

 

Accounts and notes receivable, net of allowance for doubtful accounts

 

$

731

 

Prepaid expenses and other current assets

 

17

 

Total current assets

 

748

 

PROPERTY, PLANT AND EQUIPMENT, net of accumulated depreciation

 

94

 

Total assets of discontinued operation

 

$

842

 

LIABILITIES OF DISCONTINUED OPERATION

 

 

 

CURRENT LIABILITIES:

 

 

 

Accounts payable and accrued liabilities

 

$

326

 

Total liabilities of discontinued operation

 

$

326

 

 

2004 Divestitures

 

During the first quarter of 2004, the Company completed a strategic evaluation of its operations based on certain criteria, such as strategic and financial fit, and future growth prospects. As a result, on May 6, 2004, the Company formally committed to a plan of divestiture for certain non-strategic asset groups related to its Direct Mail operations reported in the Information Management and Distribution segment in prior periods, and two medical records management operations reported in the Healthcare, Regulatory and Legal Compliance segment in prior periods. The Direct Mail operations and the two medical records management operations are accounted for as discontinued operations. As such, the results associated with these operations are presented in the consolidated statement of operations as Income (Loss) from Discontinued Operations, net of tax.

 

During the second quarter of 2004, the Company completed the sale of one of the medical records management operations, which resulted in approximately $0.7 million of cash proceeds and a pre-tax gain on disposal of approximately $0.5 million. Additionally, the Company recognized a pre-tax loss on disposal related to the Direct Mail operations of approximately $2.2 million.

 

During the third quarter of 2004, the Company completed the sale of the Direct Mail operations and the remaining medical records management operation, resulting in the recognition of a net pretax gain of $0.4 million. In connection with these transactions, the Company received approximately $6.1 million of cash proceeds, net of transaction costs, approximately $1.5 million of 12 percent secured subordinated notes, which the Company fully reserved, related to the Direct Mail operations, and $0.6 million of contingent consideration related to a contract renewal at the medical records management operation.

 

During the fourth quarter of 2004, the contingency surrounding the contract renewal at the medical records management operation was resolved. As such, the Company recognized additional consideration of $0.6 million offset by approximately $0.1 million of incremental loss related to finalizing the consideration related to the divestiture.

 

The collection of the reserved subordinated notes could result in a future reduction of the total loss related to the disposition of the Direct Mail operations.

 

Summarized selected financial information for the 2004 divestitures discussed above is as follows (in thousands):

 

 

 

Three Months Ended
March 31,

 

 

 

2004

 

2005

 

 

 

(Unaudited)

 

REVENUE

 

$

8,589

 

$

7

 

COST OF SERVICES

 

6,400

 

49

 

DEPRECIATION

 

401

 

 

Gross profit

 

1,788

 

(42

)

SELLING, GENERAL AND ADMINISTRATIVE EXPENSES

 

2,611

 

4

 

Operating loss

 

(823

)

(46

)

OTHER (INCOME) EXPENSE:

 

 

 

 

 

Interest and other expense (income), net

 

(11

)

 

Loss on sale of asset group

 

 

17

 

Loss from discontinued operations before income taxes

 

(812

)

(63

)

PROVISION (BENEFIT) FOR INCOME TAXES

 

(325

)

(24

)

LOSS FROM DISCONTINUED OPERATIONS

 

$

(487

)

$

(39

)

 

10



 

5. Business Combinations

 

Goodwill and Intangibles

 

The changes in the carrying value of goodwill and the components of intangibles are as follows (in thousands):

 

Goodwill:

 

 

 

Information
Management and
Distribution

 

Healthcare,
Regulatory
and Legal
Compliance

 

Total

 

Net balance as of January 1, 2005

 

$

167,660

 

$

158,479

 

$

326,139

 

Adjusment related to past acquisition

 

(935

)

 

(935

)

Finalize purchas price allocation

 

 

(19

(19

Net balance as of March 31, 2005

 

$

166,725

 

$

158,460

 

$

325,185

 

 

Intangibles:

 

 

 

December 31, 2004

 

March 31, 2005

 

 

 

Gross Carrying
Value

 

Accumulated
Amortization

 

Gross Carrying
Value

 

Accumulated
Amortization

 

Customer relationships

 

$

4,283

 

$

(1,084

)

$

4,283

 

$

(1,150

)

Non-compete agreements

 

2,321

 

(616

)

2,321

 

(756

)

Total

 

$

6,604

 

$

(1,700

)

$

6,604

 

$

(1,906

)

 

Aggregate amortization expense related to intangibles for the three months ended March 31, 2004 and 2005 was approximately $0.1 million and $0.2 million, respectively.  Estimated amortization expense for the periods ending December 31, 2005 through December 31, 2016 is presented in the table below.

 

Years Ending December 31,

 

Estimated Amortization
Expense

 

 

 

(in thousands)

 

2005

 

$

825

 

2006

 

825

 

2007

 

737

 

2008

 

384

 

2009

 

267

 

Thereafter

 

1,866

 

Total

 

$

4,904

 

Contingent Consideration

 

Certain of the Company’s acquisitions are subject to adjustments in overall consideration and recorded goodwill based upon the achievement of specified revenue and/or earnings targets generally over one to three year periods. In certain agreements, the Company reserves the right to change the payment mix to use common stock versus cash in satisfying contingent consideration liabilities.

 

Management’s evaluation of the cumulative earnings of acquired companies through December 31, 2004 indicated that an acquired company has met specified earnings targets beyond a reasonable doubt.  There were no changes to management’s evaluation during the three months ended March 31, 2005;  therefore, approximately $5.3 million of additional consideration remains accrued and is expected to be settled in cash during 2005.  The accrued additional consideration is included in accounts payable and accrued liabilities in the Condensed Consolidated Balance Sheets.

 

As of March 31, 2005, all periods applicable for earnout targets of past acquisitions are completed.

 

Other Accrued Consideration

 

During the three months ended March 31, 2005, no additional purchase proceeds were accrued.

 

6. Segment Reporting

 

The Company aggregates its service offerings and operations into two reportable segments: (i) Information Management and

 

11



 

Distribution, and (ii) Healthcare, Regulatory, and Legal Compliance. The Company’s reportable segments are organized around customer types and service offerings possessing similar economic characteristics. Management evaluates segment performance based on revenue and income before income taxes. All centrally incurred corporate costs are allocated to the segments based principally on operating income of the reportable segments.  The reporting segments follow the same accounting policies used for the Company’s consolidated financial statements.

 

The identified segments are as follows:

 

Information Management and Distribution.  This segment offers Business Process Outsourcing (“BPO”) solutions that help its customers manage the Document In-flow, Workflow Processing and Statement Out-flow of their mission critical business document processes. This segment’s BPO solutions enable customers to automate their complex workflow processes by digitizing large volumes of documents, capturing information from the documents, hosting electronic documents on the Company’s Web-based repository, and preparing statements that customers mail or present electronically to their end users.

 

Healthcare, Regulatory and Legal Compliance.  This segment offers specialized knowledge-based processing and consulting services that include medical records release, record management services for healthcare institutions, temporary staffing for healthcare institutions, providing managed care compliance reviews, class action claims administration sevices, and professional economic research and litigation services.

 

The Company measures segment profit as income from continuing operations before income taxes. Information on the segments follows (in thousands):

 

 

 

THREE MONTHS ENDED MARCH 31, 2005

 

 

 

Information
Management
and
Distribution

 

Healthcare,
Regulatory
and Legal
Compliance

 

Consolidated

 

Revenue

 

$

56,295

 

$

49,637

 

$

105,932

 

Income from continuing operations before income taxes

 

5,816

 

6,249

 

12,065

 

 

 

 

THREE MONTHS ENDED MARCH 31, 2004

 

 

 

Information
Management
and
Distribution

 

Healthcare,
Regulatory
and Legal
Compliance

 

Consolidated

 

Revenue

 

$

48,027

 

$

47,789

 

$

95,816

 

Income (loss) from continuing operations before income taxes

 

(1,629

)

5,920

 

4,291

 

 

7. Litigation

 

The Company is, from time to time, a party to litigation. The following is a description of the most significant legal matters that the Company is involved in.  In the event of an adverse outcome in one or more of the legal proceedings our business, financial condition, results of operations or cash flows could be materially adversely affected.

 

Putative Securities Class Action

 

The Company, and the Company’s CEO and CFO individually, have been named as defendants in several putative securities class actions, in response to the Company’s press releases dated October 27, 2004, in which the Company disclosed that its financial statements for certain prior periods should no longer be relied upon, and also provided updated financial guidance. The complaints (collectively, the “Actions”) were filed in the United States District Court for the Northern District of Texas, Dallas Division, with the first action being filed November 1, 2004. The Actions are putative shareholder class action lawsuits alleging violations of Federal Securities Laws, including alleged violations of Sections 10(b) and 20(a), and Rule 10b-5 of the Securities Exchange Act of 1934, as amended. The Actions are purportedly on behalf of all persons who purchased the Company’s common stock during the period between May 7, 2003, and October 26, 2004 or October 27, 2004, depending on the Action, and seek unspecified damages.  The four Actions have been transferred to a single judge in the Northern District of Texas, Dallas Division and these actions have been consolidated into a single action now styled In re Sourcecorp, Inc. Securities Litigation, and a lead plaintiff has been appointed.

 

Purported Derivative Action and Demand Letter

 

A purported stockholder derivative action was filed on December 28, 2004, against certain of the Company’s current and former officers and directors as individual defendants and the Company as a nominal defendant in the 116th District Court for Dallas County, Texas (the “Purported Derivative Action”). The Purported Derivative Action alleges breach of fiduciary duty, abuse of control, gross mismanagement, waste of assets, and unjust enrichment related to the Company’s press release dated October 27, 2004, in which the Company disclosed that its financial statements for certain prior periods should no longer be relied upon. All of these claims are asserted derivatively on behalf of the Company and seek unspecified damages against those individuals.  Further, the

 

12



 

Chairman of the Company’s Board of Directors received from a purported shareholder a demand letter (the “Demand Letter”) based on the same set of facts as the Purported Derivative Action.  The Demand Letter requests the Board to take certain action, but does not seek damages against the Company.  The Company has formed a special committee of the Board of Directors to evaluate the claims made in the Purported Derivative Action and the Demand Letter.

 

Digital Imaging Systems

 

On August 5, 2004, Digital Imaging Systems, Inc. filed suit against the Company in the United States District Court-Southern District of New York alleging, among other things, that a portion of the Company’s process for scanning and indexing images violates one of Digital Imaging Systems’ patents.  The Company has tendered this matter to one of its software/hardware vendors for indemnification, which such vendor has undertaken subject to pre-existing contractual conditions.  The suit demands unspecified damages.

 

Various ROI Copy Charge Matters

 

From time to time, various subsidiaries of the Company that perform release of information (“ROI”) services become defendants to putative class action lawsuits generally alleging that the charge for reproducing certain medical records is not in conformity with such plaintiffs’ reading of the applicable regulated charge. Such suits typically include multiple ROI companies and hospitals as defendants and demand reimbursement for prior charges as well as for prospective pricing adjustments. The Company is currently a party to several such suits in various stages of development.  One such suit originally styled McShane v. Recordex Acquisition Corp. & Sourcecorp, Incorporated (and now styled Liss & Marion, PC v. Recordex Acquisition Corp., & Sourcecorp, Inc.) filed February 10, 2003, in the Court of Common Pleas Philadelphia County, Pennsylvania, alleges among other things that the Company intentionally charges more for providing copies of medical records than is permitted under Pennsylvania law.  The complaint does not specify the amount of damages sought.  Plaintiff's counsel had at one time alleged damages were as high as $7 million without providing any real support for this amount; however, the Company believes that it will ultimately prevail in this matter, or if any liability is found, that the amount of damages, if any, would be substantially less than such alleged amount.  In September 2004, the court entered its order certifying a class in this matter and both the plaintiffs and the defendants have filed motions for summary judgment.

 

Spohr. et. al. v. F.Y.I. Incorporated, et. al.

 

In June 2000, the Company filed an action styled F.Y.I. Incorporated v. Spohr, et. al. in Dallas, Texas, in which it asserted claims for breach of contract, fraud, and negligent misrepresentation against the sellers of two related companies the Company acquired in December 1998 (the “Texas Action”). The Texas Action was later removed to federal court and ultimately dismissed on jurisdictional grounds. The Company reasserted these claims in two actions that were later consolidated; one styled F.Y.I. Incorporated v. Spohr, et. al. in Superior Court of the State of California in the County of Sacramento, Case No. 01-AS-00721 (the “Sacramento Action”) and one styled Spohr, et. al. v. F.Y.I. Incorporated, et. al. in the Superior Court of the State of California in the County of San Francisco, Case No. 318703 (the “San Francisco Action”). In the consolidated action, the Company additionally filed claims against the sellers’ accountants and the two sellers filed claims against the Company; however, in February 2004, the judge in the Sacramento Action dismissed the Company’s claims against the sellers’ accountants. The sellers allege that the Company’s former subsidiary wrongfully failed and refused to execute and deliver a requested estoppel certificate, and that the failure to provide such estoppel certificate harmed the landlord in that they were allegedly denied favorable terms on a refinancing of the property and were allegedly prevented from completing a timely sale of the property. Sellers alleged damages of approximately $1.5 million. The Company asserted damages in excess of $8 million. On February 3, 2005, the parties settled this matter on mutually acceptable terms.

 

8. Long-Term Customer Liability and Deferred Revenue

 

During October 2004, the Company, with the oversight and approval of the Audit Committee of its Board of Directors, initiated an investigation of the financial results of one of its operating subsidiaries in the Information Management and Distribution reportable segment (the “Operating Subsidiary”). The findings of the investigation concluded that the Operating Subsidiary had incorrectly recognized revenue for certain customer arrangements and omitted certain operating expenses from its financial results which in turn resulted in overpayments and over accruals of contingent consideration amounts due under the earn-out provisions of the acquisition agreement for the Operating Subsidiary.  The overpayments and over accruals of contingent consideration amounts had been originally recognized as additional goodwill of the acquired business.

 

As described in the Company’s critical accounting policies, revenue is recognizable when each of the following conditions is met: persuasive evidence of an arrangement exists, the price is fixed or determinable, delivery has occurred or services have been rendered and collection is reasonably assured. The investigation identified certain instances where one or more of the aforementioned revenue recognition conditions as applied to certain customer contracts were not met by the Operating Subsidiary. As a result, the revenue previously recognized that did not meet all the mentioned revenue recognition conditions was reversed, resulting in a downward adjustment to certain asset accounts or the recognition of a customer liability or deferred revenue. 

 

During the first quarter of 2005, the Company entered into an agreement with one of its customers impacted by the facts relating to the subject of the internal investigation.  As a result of the agreement, during the first quarter of 2005, the Company recognized remediation revenue of $4.1 million related to revenue reversals; however, such revenue did not contribute to the Company’s operating cash flow in the current year. 

 

Additionally, during the first quarter of 2005, agreements from other customers impacted by the facts relating to the subject of the internal investigation were received and the customer agreed to apply certain balances, classified as long-term customer liability and/or deferred revenue, against current trade accounts receivable the Company has outstanding from such customers.  The net amount applied against trade accounts receivable during the first quarter of 2005 was approximately $0.6 million.  

 

13



 

The balances classified as Long-Term Customer Liability and Deferred Revenue related to customers impacted by the facts relating to the subject of the internal investigation are as follows (in thousands):

 

 

 

December 31,
2004

 

March 31,
2005

 

Long-Term Customer Liability

 

$

4,147

 

$

1,305

 

Deferred Revenue

 

8,010

 

6,155

 

Total

 

$

12,157

 

$

7,460

 

 

The remaining balances at March 31, 2005, will be recognized when finalized and in accordance with agreements negotiated and finalized with each applicable customer.

 

14



 

Item 2.      Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Overview

 

We were founded in September 1994, to create a national, single source provider of document and information outsourcing solutions to document and information intensive industries, including healthcare insurance, financial services, healthcare provider, transportation/logistics, federal and state government, and legal industries.  We acquired the seven founding companies (the “Founding Companies”) simultaneously with the closing of our initial public offering (the “IPO”) on January 26, 1996, and effectively began operations at that time. The consideration for the Founding Companies consisted of a combination of cash and common stock of our Company. 

 

Since the IPO and through March 31, 2005, we have acquired 66 companies and divested 22 operating units by sales or closures. We evaluate candidates for acquisition and periodically for divestiture as a part of our strategic plan of providing customers a single solution for business process outsourcing and knowledge-based processing and consulting services. The criteria for evaluation include geographic need, additional technology, market growth potential, industry expertise, service expansion to broaden service offerings, expansion of our customer base, revenue and earnings growth potential, and expected sources and uses of capital.

 

On May 4, 2004, we announced the acquisition of KeyPoint Consulting, LLC (“KeyPoint”).  KeyPoint is an economic consulting firm with approximately 26 principals and staff, and a network of academic affiliates.  KeyPoint provides economic, financial, and forensic accounting services in matters involving complex litigation and regulation.  KeyPoint’s clients include companies, law firms, and government and regulatory agencies.  The acquisition of KeyPoint significantly expands our expertise in new practice areas and helps us strategically position for additional growth in our legal consulting area.  KeyPoint joined our legal consulting service offering and is reported in the Healthcare, Regulatory and Legal Compliance segment. Key Point contributed $5.6 million in revenue in 2004, or approximately 2.9% of total segment revenue, and was moderately accretive to 2004 earnings after consideration of related financing costs and amortization of identified intangibles.

 

During the first quarter of 2004, we completed a strategic evaluation of our operations based on certain criteria, such as strategic and financial fit, and future growth prospects.  As a result, on May 6, 2004, we formally committed to a plan of divestiture for certain non-strategic asset groups.  The asset groups to be divested included our Direct Mail operations, previously reported in our Information Management and Distribution segment, and two medical records management operations that were reported in our Healthcare, Regulatory and Legal Compliance segment. Collectively, these asset groups incurred losses, net of tax, of $0.8 million for the full year ended December 31, 2003.  During the quarter ended June 30, 2004, we completed the sale of one of the medical records management operations.  The divestiture of the other medical records management operation and the Direct Mail operations were completed during the quarter ended September 30, 2004.  See Note 4, Discontinued Operations, of Notes to Condensed Consolidated Financial Statements, for a more detailed discussion. 

 

During the first quarter of 2005, we completed the sale of an asset group that provides computer application software and services to the public sector.  This asset group was related to our litigation services operations and was previously reported in our Healthcare, Regulatory and Legal Compliance segment.  This asset group incurred losses, net of tax, of $0.2 million for the full year ended December 31, 2004.  See Note 4, Discontinued Operations, of Notes to Condensed Consolidated Financial Statements, for a more detailed discussion.

 

Basis for Management Discussion and Analysis

 

The following discussion and analysis focuses on the results of operations and financial condition from the Company’s continuing operations; as such, in accordance with Statement of Financial Accounting Standards No. 144, references and comparisons to prior periods exclude the impact of our discontinued operations.

 

Our revenue possesses both project and recurring characteristics.  Project revenue includes one-time projects in which the customer relationship is not expected to continue after project completion. Project revenue margins are usually higher than our average margins and the workload can be highly volatile.  Project revenue is typically based on time and material arrangements and predominately occurs within the Healthcare, Regulatory and Legal Compliance segment.  Recurring revenue is characterized by customer relationships that are generally for one year and may continue for longer.  Recurring revenue is typically based on transaction volumes sent to us by our customers at an agreed upon fixed rate per unit.  Our customers’ volumes are generally not contractually or otherwise guaranteed.  Recurring revenue typically possesses lower margins than project revenue but is usually more predictable.

 

Cost of services consists primarily of compensation and benefits to employees providing goods and services to our clients; occupancy costs; equipment costs and supplies. Our cost of services also includes, to a limited extent, the cost of products sold for micrographics supplies and equipment; computer hardware and software; and business imaging supplies and equipment.

 

15



 

Selling, general and administrative expenses (“SG&A”) consist primarily of compensation and related benefits to sales and marketing, executive management, accounting, human resources and other administrative employees; other sales and marketing costs; communications costs; insurance costs; and legal and accounting professional fees and expenses.

 

In addition, the condensed consolidated financial statements included in Item 1 “Financial Statements”, should be read in conjunction with our consolidated financial statements and the related notes thereto in the Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 31, 2005.

 

Business Segments

 

We aggregate our service offerings and operations into two reportable segments: (i) Information Management and Distribution, and (ii) Healthcare, Regulatory, and Legal Compliance. Service offerings are aggregated when they are similar in the following areas: economic characteristics, products and services, production processes, methods for distributing or delivering products, and type or class of customers. We evaluate segment performance based on revenue and income before income taxes. All centrally incurred corporate costs are allocated to the segments based principally on operating income of the reportable segments. The reporting segments follow the same accounting policies used for our consolidated financial statements as described in the summary of critical accounting policies.

 

The identified segments are as follows:

 

Information Management and Distribution.  We offer Business Process Outsourcing (“BPO”) solutions that help our customers manage the Document In-flow, Workflow Processing and Statement Out-flow of their mission critical business document processes. Our BPO solutions enable customers to automate their complex workflow processes by digitizing extremely large volumes of documents, capturing information from the documents, hosting electronic documents on our Web-based repository, and preparing statements that customers mail or present electronically to their end users.  We offer our BPO solutions to businesses in document intensive industries, such as healthcare insurance, financial services, healthcare provider, transportation/logistics, and federal and state government.  For the three months ended March 31, 2004 and 2005, revenue in the Information Management and Distribution segment consisted of approximately $43.1 million and $47.9 million of recurring revenue, respectively, and $4.9 million and $8.4 million of project revenue, respectively. 

 

Healthcare, Regulatory and Legal Compliance.  We offer specialized knowledge-based processing and consulting services that include medical records release, record management services for healthcare institutions, temporary staffing for healthcare institutions, temporary staffing for healthcare institutions, providing managed care payment compliance reviews, class action claims administration services, professional economic research and litigation services, and tax benefit services. For the three months ended March 31, 2004 and 2005, revenue in the Healthcare, Regulatory and Legal Compliance segment consisted of approximately $18.2 million and $18.7 million of recurring revenue, respectively, and $29.6 million and $30.9 million of project revenue, respectively. 

 

Internal Investigation

 

During October 2004, the Company, with the oversight and approval of the Audit Committee of our Board of Directors, initiated an investigation of the financial results of one of our operating subsidiaries in the Information Management and Distribution reportable segment (the “Operating Subsidiary”). The findings of the investigation concluded that the Operating Subsidiary had incorrectly recognized revenue for certain customer arrangements and omitted certain operating expenses from its financial results which in turn resulted in overpayments and over accruals of contingent consideration amounts due under the earn-out provisions of the acquisition agreement for the Operating Subsidiary.  The overpayments and over accruals of contingent consideration amounts had been originally recognized as additional goodwill of the acquired business.

 

As described in our critical accounting policies, revenue is recognizable when each of the following conditions is met: persuasive evidence of an arrangement exists, the price is fixed or determinable, delivery has occurred or services have been rendered and collection is reasonably assured. Our investigation identified certain instances where one or more of the aforementioned revenue recognition conditions as applied to certain customer contracts were not met by the Operating Subsidiary. As a result, the revenue previously recognized that did not meet all the mentioned revenue recognition conditions was reversed, resulting in a downward adjustment to certain asset accounts or the recognition of a customer liability or deferred revenue. 

 

During the first quarter of 2005, we entered into an agreement with one of our customers impacted by the facts relating to the subject of our internal investigation.  As a result of the agreement, during the first quarter of 2005, we recognized remediation revenue of $4.1 million related to revenue reversals; however, such revenue did not contribute to the Company’s operating cash flow in the current year.  We expect to recognize additional remediation revenue of approximately $3.0 million during the second quarter of 2005.  Although the exact timing is indeterminable, additional remediation revenue may be recognized in future periods in accordance with agreements negotiated and finalized with each applicable customer.

 

16



 

THREE MONTHS ENDED MARCH 31, 2004 COMPARED TO THREE MONTHS ENDED MARCH 31, 2005

 

 

 

Three Months Ended March 31,

 

 

 

2004

 

2005

 

 

 

($000’s)

 

% of
Revenue

 

($000’s)

 

% of
Revenue

 

Revenue

 

$

95,816

 

100.0

%

$

105,932

 

100.0

%

Gross Profit

 

36,223

 

37.8

%

43,973

 

41.5

%

SG&A

 

31,068

 

32.4

%

30,221

 

28.5

%

Operating income

 

5,066

 

5.3

%

13,546

 

12.8

%

Income from continuing operations before income taxes

 

4,291

 

4.5

%

12,065

 

11.4

%

Income from continuing operations

 

2,575

 

2.7

%

7,355

 

6.9

%

 

Revenue

 

Our operations generated revenues of $105.9 million for the three months ended March 31, 2005, an increase of 10.6% compared to the same period in 2004.  During the second quarter of 2004, we acquired KeyPoint Consulting, LLC (“KeyPoint”) as a part of our Healthcare, Regulatory and Legal Compliance segment.  KeyPoint contributed approximately $1.9 million to the revenue increase.  In addition, as previously discussed, during the first quarter of 2005, we recognized remediation revenue of $4.1 million related to revenue reversals in previous years.  After considering the positive revenue variance related to the KeyPoint acquisition and the remediation revenue, our remaining operations achieved revenue growth of 4.4% during the first quarter of 2005.  This revenue growth resulted primarily from strong volumes in our information management service offering and in our project oriented class action claims administration service offering that contributed approximately $4.4 million and $2.1 million, respectively.  Including the KeyPoint acquisition, project revenue accounted for $39.3 million or 37.1% of revenue in the current year quarter compared to $34.5 million or 36.1% of revenue in the prior year quarter. (See “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Basis for Management Discussion and Analysis.”)

 

Revenues within our Information Management and Distribution segment increased 17.2% from $48.0 million for the three months ended March 31, 2004, to $56.3 million for the three months ended March 31, 2005.  The increase in segment revenues were primarily the result of: (i) 2004 new business wins converted to revenue during 2005 contributing approximately $4.6 million, particularly in our healthcare payer, federal and state government and mortgage vertical markets, and (ii) the previously discussed remediation revenues of $4.1 million related to revenue reversals in previous years.  Revenues in the statement processing service offering were slightly down when compared to the prior year quarter.

 

Revenues within our Healthcare, Regulatory and Legal Compliance segment increased 3.9% from $47.8 million for the three months ended March 31, 2004, to $49.6 million for the three months ended March 31, 2005. The acquisition of KeyPoint contributed approximately $1.9 million to the increase.  Also contributing to the revenue increase were higher volumes of small to medium size projects (i.e. projects with less than $500k of total revenue) in our class action claims administration service offering, which increased approximately $2.1 million or 24%.  Offsetting increases in segment revenues were lower revenues of approximately $2.0 million in our healthserve service offerings principally due to lower demand for medical record coding staffing services and customer attrition within our medical records release services.

 

Gross profit

 

Gross profit increased 21.4% from $36.2 million, or 37.8% of revenue, for the three months ended March 31, 2004, to $44.0 million, or 41.5% of revenue, for the three months ended March 31, 2005.  Gross margin increased 370 basis points primarily due to: (i) the previously discussed remediation revenues of $4.1 million contributing 230 basis points, and (ii) lower production personnel cost as a percentage of revenue contributing 170 basis points.  Gross margin improvement resulting from personnel costs occurred in our information management service offering due to productivity and quality initiatives which included:  introduction of Lean/Six Sigma quality initiatives, implementation of high speed scanning technology to replace labor intensive low speed scanners, implementation of pay for performance compensation strategies, and increased utilization of offshore labor.

 

Selling, general and administrative expenses

 

SG&A decreased 2.7% from $31.1 million, or 32.4% of revenue, for the three months ended March 31, 2004, to $30.2 million, or 28.5% of revenue, for the three months ended March 31, 2005. The decrease in SG&A expense relates primarily to lower legal expense in the current year quarter.  During the first quarter of 2004, we experienced $4.9 million of higher legal expense primarily due to the settlement of a significant legal matter within our Information Management and Distribution segment.  Lower current year legal expense was partially offset by the following items: (i) $1.3 million of investigation costs incurred during the current year quarter, (ii) $0.6 million of incremental SG&A related to the Keypoint acquisition which was acquired during the second quarter of 2004, and (iii) $2.5 million of higher personnel related cost.  We have experienced higher personnel related costs as a result of the

 

17



 

following: (i) investment in management and sales resources within our class action claims administration service offering, (ii) investment in technology and sales resources within our information management service offering, and (iii) higher incentive compensation related to recent new business win successes and improved year over year performance. 

 

Income from continuing operations before income taxes

 

Income from continuing operations before income taxes increased from $4.3 million for the three months ended March 31, 2004 to $12.1 million for the three months ended March 31, 2005.  The increase was due to the factors impacting gross profit and SG&A discussed above.  Offsetting the positive factors was higher interest expense in the current year quarter of approximately $0.6 million due to higher average debt balances and a higher interest rate environment.  Each 100 basis point increase in interest rates results in incremental interest expense of approximately $0.8 million at current debt levels.

 

Provision for income taxes

 

During the first quarter of 2005, our effective tax rate decreased to 39% from the 40% tax rate in effect during 2003 and in effect during 2004 prior to tax benefits received from the favorable resolution of certain open tax issues and favorable resolution of certain strategic tax positions.  The reduction in effective rate is due to acquisitions, divestures and changes in business mix between various taxing jurisdictions.  We expect the lower effective tax rate of 39% to be sustainable throughout 2005.

 

LIQUIDITY AND CAPITAL RESOURCES

 

At March 31, 2005, we had $41.7 million of working capital, including $0.2 million of cash.  Working capital at December 31, 2004 was $34.1 million, including $3.7 million of cash.  For the first three months of 2005, net cash used in operating activities from continuing operations was $4.4 million compared to cash provided by operating activities from continuing operations of $0.1 million for the same period in 2004.  Key factors contributing to the net cash used by operating activities from continuing operations consist of: (i) increased accounts receivable balances related to slower collections of approximately $1.6 million and higher revenue in the current quarter, (ii) changes in compensation related accruals of approximately $4.0 million due to annual incentive compensation payments during the quarter and the timing of payroll fundings at the end of the current quarter, (iii) utilization of customer deposits of approximately $2.2 million related primarily to current projects within our class action claims administration service offering and (iv) approximately $0.6 million of net payments related to the previously discussed internal investigation completed during the current year quarter.

 

Although working capital fluctuations had a significant impact on operating cash flow during the current year quarter, based on our current expectations of full year operating results and expectations regarding improvements in accounts receivable collections, we expect to achieve an operating cash flow level for 2005 within a range of $35 million to $50 million. 

 

Days sales outstanding decreased two business days during the quarter to 43 business days at March 31, 2005, compared to 45 business days at December 31, 2004.  Excluding the positive effects of the remediation revenue recognized during the quarter, days sales outstanding at March 31, 2005, were 45 business days.

 

For the three months ended March 31, 2005, investing activities from continuing operations consisted of acquisitions of property, plant and equipment of $5.7 million, partially offset by divestiture proceeds of $0.2 million, related to the divestiture of a non-strategic asset group related to our litigation services operations.  Some future quarters will include additional settlements of contingent consideration on past acquisitions.  Management’s evaluation of the cumulative earnings of acquired companies through December 31, 2004 indicated that an acquired company has met specified earnings targets beyond a reasonable doubt.  Therefore, approximately $5.3 million of additional consideration remains accrued which is classified as other current liabilities and is expected to be settled in cash during 2005.

 

Net cash provided by financing activities from continuing operations was $6.7 million for the three months ended March 31, 2005.  Borrowings from our line of credit of $53.0 million were partially offset by payments on our line of credit of $46.3 million.  We utilize our line of credit to fund general operating requirements of the Company as well as fund significant investments such as acquisitions or capital expenditures.

 

In April 2001, we entered into a line of credit agreement with Bank of America, SunTrust Bank and Wells Fargo Bank, as co-agents (the “2001 Credit Agreement”). Under this agreement, we could from time to time borrow funds up to $297.5 million through April 2, 2004, subject to certain financial covenants and ratios. Meeting these requirements is highly dependent upon maintaining a minimum level of operating results and the continued demand for our services, among other factors.

 

Effective April 3, 2002, we extended $220.0 million of the $297.5 million commitment for an additional year to April 2, 2005. In September 2002, additional extensions were granted by member banks, bringing the total commitment extended to April 2, 2005, to $290.0 million. Total fees paid in 2002 related to the extensions and amendments to the 2001 Credit Agreement were $0.3 million.

 

18



 

Effective April 3, 2003, we extended $230.0 million of the $297.5 million commitment to April 1, 2006. During the fourth quarter of 2003, a participating bank in the 2001 Credit Agreement assigned $7.5 million of its commitment to another bank who, effective December 4, 2003, extended this commitment to April 1, 2006. Total fees paid in 2003 related to the extensions and amendments to the 2001 Credit Agreement were $0.3 million.

 

At March 31, 2005, the remaining commitment under the 2001 Credit Agreement is $290.0 million and is scheduled to mature as follows (in millions):

 

Maturity Date

 

Commitment

 

Remaining
Commitment

 

April 2, 2005

 

$

52.5

 

$

237.5

 

April 1, 2006

 

237.5

 

 

 

Total

 

$

290.0

 

 

 

 

As of March 31, 2005, we are in compliance with loan covenants after giving effect to the amendments and waivers discussed below, which among other things provided for an amended definition of EBITDA.  As of March 31, 2005, the availability under the 2001 Credit Agreement was approximately $24.5 million.

 

Our ability to borrow is contingent on certain leverage and fixed cost coverage ratios. These ratios were scheduled to become more restrictive beginning in the quarter ended December 31, 2002 with the leverage ratio declining from 3.0 times to 2.5 times and the fixed charge coverage ratio increasing from 1.25 times to 1.50 times. However, in September 2002, an amendment was approved that extended the fixed cost coverage ratio requirement of 1.25 until January 1, 2004 and will increase to 1.35 at all times thereafter. In addition to the leverage and fixed cost coverage ratios, we are subject to minimum net worth requirements. Effective March 26, 2003, an amendment was approved that allows for the reduction to the minimum net worth requirement for up to $30 million of share repurchases. In addition, effective July 30, 2004, an amendment was approved that allows for the reduction to the minimum net worth requirement for an additional $30 million of share repurchases.

 

As a result of our internal investigation, described above in “Internal Investigation”, we were unable to file our September 30, 2004 Quarterly Report on Form 10-Q within the timeframe prescribed by the Securities Exchange Act of 1934.  The failure to timely file the September 30, 2004 Quarterly Report on Form 10-Q resulted in a default under the 2001 Credit Agreement.  We entered into a waiver agreement on November 12, 2004 with the lenders party to the 2001 Credit Agreement.  Pursuant to the terms of the waiver agreement, the lenders agreed, among other things, to waive any default under the 2001 Credit Agreement that resulted from potential non-compliance with a designated fixed charge coverage ratio, and our failure to timely file our Quarterly Report on Form 10-Q for the September 30, 2004 quarter.  The waiver agreement also provides that during the period that the waiver agreement is in effect, the outstanding principal amount of the loans under the 2001 Credit Agreement may not exceed $112,000,000. The waiver agreement was to expire on March 15, 2005;  however, on March 15, 2005, we entered into on Extension and Modification of Waiver to Credit Agreement, which extended such waiver through March 23, 2005.

 

Effective March 23, 2005, we entered into an amendment to the 2001 Credit Agreement that allows for the exclusion of certain contingent consideration overpayments to the former owners of the Operating Subsidiary, as discussed above, from the definition of Earnings Before Interest, Taxes, Depreciation and Amortization (“EBITDA”). Pursuant to the terms of the Company’s 2001 Credit Agreement, EBITDA is used in calculating certain leverage and fixed cost coverage ratios. By not having the March 23, 2005 amendment in place, the Company was in a default under the 2001 Credit Agreement due to the Company exceeding the allowable leverage ratio of 2.5 times for the quarters ended June 30, 2004 and September 30, 2004 as a result of certain contingent consideration overpayments discussed above in “Internal Investigation”.  As a result, the Company classified the debt under such Credit Agreement as a Current Maturity included in the current liability section of its balance sheet at June 30 and September 30, 2004. Upon entering the March 23, 2005 amendment, the Company cured the default under the 2001 Credit Agreement, as such, reclassifying debt under the Credit Agreement as Long-Term Obligations. In any event, as the maturity date of the debt under the 2001 Credit Agreement is April 1, 2006, unless the maturity date of such debt is subsequently modified, such debt will be classified as a Current Maturity on and after April 1, 2005

 

Management believes that it has sufficient liquidity from its cash flow and its revolving credit facility to meet ongoing business needs.  Additionally, depending on the mix of stock and cash used in our strategic acquisition program, if any, we may need to seek further financing through the public or private sale of equity or debt securities.  However, there can be no assurance we could secure such financing if and when it is needed or with terms we deem acceptable.

 

Management fully expects to replace or refinance the 2001 Credit Agreement upon its maturity scheduled for April 1, 2006.

 

In January 2000, we registered on Form S-4 (Registration No. 333-92981) 3,012,217 shares of common stock for issuance in connection with our acquisition program (the “Acquisition Shelf”), of which 1,359,852 shares were available as of March 31, 2005; however, such registration statement may require amendment prior to use.

 

19



 

Critical Accounting Policies

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations are based on the related consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of the financial statements requires the use of estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses.

 

We have identified the following critical accounting policies that, as a result of the judgments, uncertainties, uniqueness and complexities of the underlying accounting standards and operations involved, could result in material changes to our financial condition or results of operations under different conditions or using different assumptions. We apply a consistent methodology at the end of each quarter to determine our account balances that require judgmental analysis.

 

Revenue Recognition.   Revenue is recognized as it becomes realized or realizable and earned according to the criteria provided by Staff Accounting Bulletin 104, Revenue Recognition. Revenue recognition occurs once persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the sales price is fixed or otherwise determinable, and collection is reasonably assured. Our revenue-earnings activities possess project and recurring customer relationships.

 

Project revenue includes one-time projects in which the customer relationship is not expected to continue after project completion. Project revenue is typically based on time and material arrangements. Revenue recognition occurs at the contractual rates as the labor hours and direct expenses are incurred. Project revenue represents approximately 34% of total 2004 revenues and typically occurs within our Healthcare, Regulatory, and Legal Compliance segment.

 

Recurring revenue is characterized by customer relationships that are generally for one year and may continue for longer. Recurring revenue is typically based on the transaction volumes provided by our customers at an agreed upon fixed rate per unit. Our customer’s volumes are typically not contractual or otherwise guaranteed. Revenue recognition occurs once work is completed and delivery has occurred or services have been rendered. Recurring revenue represents 66% of total 2004 revenues and typically occurs within our Information Management and Distribution segment.

 

Revenue recognition policies related to offerings within our Information Management and Distribution segment are based upon objective criteria that do not require significant estimates or uncertainties. For example, business process outsourcing services are recognized proportionally as services are rendered, based on specific, objective criteria under the contracts for the number of accounts or transactions processed. Accordingly, revenues recognized under these methods do not require the use of significant estimates that are susceptible to change.

 

Revenue recognition policies within our Healthcare, Regulatory, and Legal Compliance segment are based upon objective criteria that do not require significant estimates or uncertainties.  For example, transaction volumes and time and costs under time and material and cost reimbursable arrangements are based on specific, objective criteria under the contracts.  The following outlines specific revenue recognition policies related to certain offerings within this segment:

 

Medical records release services — revenue is recognized upon completion of the processing of the requested medical records.  Revenue recognition for this service is based on an agreed upon and in some cases, a regulated rate applied to the number of records processed.  When a fee is paid to the hospital, the revenue related to that fee is reported on a net basis in accordance with Emerging Issues Task Force (“EITF”) 99-19, Reporting Revenue Gross as a Principal versus Net as an Agent, due to the fact that: (a) the primary obligation in the arrangement is borne partially by both SOURCECORP and the hospital; (b) SOURCECORP has no discretion with respect to the supplier of the medical record; and (c) SOURCECORP is not involved in the determination of product or service specifications.

 

Record management services — revenue is recognized as storage services are provided based linear feet of documents stored times a monthly rate for shelf storage and based on a monthly per image rate for images stored electronically.  We recognize fees for processing, retrieval, delivery and return to storage as revenue upon completion of the service at the agreed upon rate applied to the unit count of items serviced.

 

Additional healthcare and compliance services — revenue is recognized for document and data conversion services as the services are provided based upon an agreed upon rate per patient file applied to the number of files processed.  Storage and archiving fees are recognized as revenue as the services are provided based upon an agreed upon monthly rate per file stored or otherwise archived.  Revenue related to coding and abstracting of medical records and staffing services is recognized as the services are provided based on an agreed upon rate applied to the billable hours worked and eligible out-of-pocket expenses defined by the service agreement.  The out-of-pocket expense component is recognized as revenue and cost of services on a gross basis in accordance with EITF Issue 01-14, Income Statement Characterization of Reimbursements Received for “Out-of-Pocket” Expenses Incurred.  Revenue related to compliance reviews is based primarily on an agreed upon percentage (or commission) of amounts identified and recovered from the third party payers as a fee for services provided.  Revenue is recognized upon successful recovery of underpayments to our clients by their managed care and commercial payers at the agreed upon percentage (or commission).

 

20



 

Class action claims administration services — revenue is recognized as these services are provided based on the agreed upon rate applied to the number of hours spent providing services related to administering the legal settlements and expenses incurred.  The out-of-pocket expense component is recognized as revenue and cost of services on a gross basis in accordance with EITF Issue 01-14, Income Statement Characterization of Reimbursements Received for “Out-of-Pocket” Expenses Incurred.  In addition, revenue related to the design and implementation of comprehensive notification plans is based on an agreed upon percentage (i.e., commission) of the cost to place the media communication.  Revenue is recognized at the time of public delivery of the notification through the various media outlets at the agreed upon percentage (or commission).

 

Professional economic research and litigation services — revenue is recognized as these services are provided based on consulting hours worked at agreed upon rates at the time services are rendered and expenses are incurred.  The out-of-pocket expense component is recognized as revenue and cost of services on a gross basis in accordance with EITF Issue 01-14, Income Statement Characterization of Reimbursements Received for “Out-of-Pocket” Expenses Incurred.

 

As a part of providing services to our customers, we incurs incidental expenses commonly referred to as “out-of-pocket” expenses. These expenses include items such as airfare, hotels, mileage, etc. and are often reimbursable by our customers. When reimbursable, we record both revenue and direct cost of services in accordance with the provisions of EITF Issue 01-14, Income Statement Characterization of Reimbursements Received for “Out-of-Pocket’ Expenses Incurred.

 

Unearned income, included in other current liabilities, represents payments from the Company’s customers in advance of services being provided. Advanced payments are deferred as unearned income when received and recognized as revenue as services are rendered.

 

Allowance for Doubtful Accounts.  The allowance for doubtful accounts is established and maintained based on our estimate of accounts receivable collectibility. Management estimates collectibility by specifically analyzing accounts receivable aging and other historical factors that affect collections. Such factors include the historical trends of write-offs and recovery of previously written-off accounts, the financial strength of the customer and projected economic and market conditions. The evaluation of these factors involves subjective judgments and changes in these factors may significantly impact our consolidated financial statements.

 

Long-Lived Asset and Other Intangible Asset Impairment.  As required by SFAS No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets, management continually evaluates whether events and circumstances indicate that the carrying value of long-lived assets and intangible assets may not be recoverable. When events require, management performs the valuation by comparing the estimated undiscounted future cash flows over the remaining life of the long-lived assets and intangible assets to the carrying amount of the asset being evaluated. An impairment loss is recognized if the carrying amount of assets being evaluated exceeds the expected future undiscounted cash flow based on the difference between the carrying value and fair value..

 

Goodwill Impairment.  On January 1, 2002, we adopted SFAS No. 142, Goodwill and Other Intangible Assets. This statement states that goodwill and intangible assets that have indefinite useful lives will not be amortized but rather will be tested at least annually for impairment. Our annual impairment test is performed at October 31.  The impairment test is based on fair value rather than undiscounted cash flows. Additionally, goodwill is tested at a reporting unit level rather than the individual operating unit level. A reporting unit is either at the operating segment level or one reporting level below and could consist of several service offerings aggregated into a single reporting unit. Service offerings are aggregated when they are similar in the following areas: economic characteristics, products and services, production processes, methods for distributing or delivering products, and type or class of customers. Valuation methods used in determining fair value include an analysis of the cash flows that the reporting units can be expected to generate in the future (Income Approach) and the fair value of a reporting unit as compared to similar publicly traded companies (Market Approach). In preparing these valuations, management utilizes estimates to determine fair value of the reporting units. These estimates include future cash flows, growth rates, capital needs, and projected earning margins among other factors. Estimates utilized in future calculations could differ from estimates used in the current period. Future years’ estimates that are unfavorable compared to current estimates could cause an impairment of goodwill and other intangible assets. Due to the fact that we are primarily a services company, our business acquisitions typically result in significant amounts of goodwill and other intangible assets. Therefore, an impairment charge resulting from goodwill or other intangible assets could result in a material adverse impact on our financial statements during the period incurred.

 

Self-Insurance Liabilities and Reserves.  We are self-insured for workmen’s compensation liabilities and a significant portion of our employee medical costs. We account for our self-insurance programs based on actuarial estimates of the amount of loss inherent in that period’s claims, including losses for which claims have not been reported. These loss estimates rely on actuarial observations of ultimate loss experience for similar historical events. We limit our risk by carrying stop-loss policies for significant claims incurred for both workmen’s compensation liabilities and medical costs. SOURCECORP’s exposure under the stop-loss policies for workmen’s compensation and medical costs is limited based on fixed dollar amounts.  For workman’s compensation, the fixed dollar amount of stop-loss coverage is $500,000 per occurrence.  For medical costs, the fixed dollar amount of stop-loss coverage is $100,000 per covered participant for the fiscal plan year, with a lifetime limit of liability per covered participant of $1,900,000.

 

21



 

Other Loss Contingencies.  We record liabilities when it is probable that a liability has been incurred and the amount of the loss is reasonably estimable in accordance with SFAS No. 5, Accounting for Contingencies. Disclosure is required when there is a reasonable possibility that the ultimate loss will exceed the recorded provision. Contingent liabilities are often resolved over long periods of time. Estimating probable losses requires analysis of multiple forecasts that often depend on judgments about potential actions by third parties such as regulators. Our loss contingencies consist primarily of estimates related to the probable outcome of current litigation.

 

RISKS ASSOCIATED WITH FORWARD-LOOKING STATEMENTS

 

This Report contains certain forward-looking statements such as our intentions, hopes, beliefs, expectations, strategies, predictions or any other variation thereof or comparable phraseology of our future activities or other future events or conditions within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Act”), and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including, without limitation, the actual final costs of our internal investigation, the Company’s ongoing SEC investigation, the potential impairment of our ability to enter into government contracts as a result of the conduct that was the subject of our investigation, remediation costs relating to our investigation, the potential customer impact of the results of our investigation, the effect of our investigation and financial statement restatement on the trading price of our stock, the risk of integrating our operating companies, of managing our rapid growth, of the timing and magnitude of technological advances, of the occurrences of future events that could diminish our customers’ needs for our services, of a change in the degree to which companies continue to outsource business processes, of an adverse outcome in any given legal proceeding or claim, of the denial of insurance on a particular claim or of a party obligated to provide indemnification being financially unable to do so, as well as such other risks set forth under the heading Risk Factors included in our most recent annual report on Form 10-K.

 

Although we believe that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and, therefore, there can be no assurance that the forward-looking statements included in this Report will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as a representation by us or any other person that our objectives and plans will be achieved. Further, we disclaim any obligation to update any such forward-looking statements, except as required by law.

 

Item 3.     Quantitative and Qualitative Disclosures about Market Risk

 

We are subject to interest rate risk on our term loans, revolving credit facility and Industrial Revenue Bonds. A 100 basis point increase in short-term interest rates would result in approximately $0.8 million of additional expense in 2005 based on our expected average balance outstanding under the credit facility during 2005. Interest rates are fixed on the capitalized lease obligations.

 

22



 

Item 4.    Controls and Procedures

 

(a) Evaluation of disclosure controls and procedures.

 

The Company maintains disclosure controls and procedures, which it has designed to ensure that material information related to the Company, including its consolidated subsidiaries, is made known to a group comprised of designated members of the Company’s senior management, designated members of functional divisions of the Company, and/or the certifying officers (i.e. Chief Executive Officer and Chief Financial Officer) (collectively, the “Disclosure Committee”), on a timely basis and that information required to be disclosed in reports it files under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms.  As of March 31, 2005, the Company carried out an evaluation, under the supervision and with the participation of the Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to Securities Exchange Act of 1934, as amended, Rule 13a-15 and 15d-15. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures are effective in timely alerting them to material information relating to the Company (including its consolidated subsidiaries) required to be included in the Company’s periodic SEC Filings.  Because of the inherent limitations of disclosure controls, including the possibility of collusion or improper management override of controls, no matter how comprehensive or well designed such controls are, management may not in all cases be alerted to material information relating to the Company (including its consolidated subsidiaries) required to be included in the Company’s periodic SEC filings.

 

(b) Changes in internal controls.

 

During the most recent fiscal quarter, there have been no changes to the Company’s internal controls over financial reporting that occurred since the beginning of the Company’s first quarter of 2005 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

However, during the first quarter of 2005, the following changes were made to the Company's internal control environment as a result of its policy of continuous control improvement:

 

      The management reporting relationship was changed for the accounting processing functions of three operating subsidiaries.  Formerly, the employees responsible for the accounting processing functions of these operating subsidiaries reported through the operational management structure.  These employees began reporting through the Company’s corporate accounting department’s management structure during the most recent fiscal quarter.  As a result, all employees responsible for accounting processing functions at all of the Company’s operating subsidiaries report through the Company’s corporate accounting department’s management structure as of January 27, 2005.

 

      In order to help ensure compliance with the Company’s adopted internal controls, individual incentive compensation plans for designated senior managers were modified to include criteria related to the effectiveness in which the Company’s internal controls are applied.

 

PART II. OTHER INFORMATION

 

Item 1.       Legal Proceedings

 

We are, from time to time, a party to litigation. The following is a description of the most significant legal matters that we are involved in.  In the event of an adverse outcome in one or more of our legal proceedings our business, financial condition, results of operations or cash flows could be materially adversely affected.

 

Putative Securities Class Action

 

The Company, and the Company’s CEO and CFO individually, have been named as defendants in several putative securities class actions, in response to the Company’s press releases dated October 27, 2004, in which the Company disclosed that its financial statements for certain prior periods should no longer be relied upon, and also provided updated financial guidance. The complaints (collectively, the “Actions”) were filed in the United States District Court for the Northern District of Texas, Dallas Division, with the first action being filed November 1, 2004. The Actions are putative shareholder class action lawsuits alleging violations of Federal Securities Laws, including alleged violations of Sections 10(b) and 20(a), and Rule 10b-5 of the Securities Exchange Act of 1934, as amended. The Actions are purportedly on behalf of all persons who purchased the Company’s common stock during the period between May 7, 2003, and October 26, 2004 or October 27, 2004, depending on the Action, and seek unspecified damages.  The four Actions have been transferred to a single judge in the Northern District of Texas, Dallas Division and these actions have been consolidated into a single action now styled In re Sourcecorp, Inc. Securities Litigation, and a lead plaintiff has been appointed.

 

23



 

Purported Derivative Action and Demand Letter

 

A purported stockholder derivative action was filed on December 28, 2004, against certain of the Company’s current and former officers and directors as individual defendants and the Company as a nominal defendant in the 116th District Court for Dallas County, Texas (the “Purported Derivative Action”). The Purported Derivative Action alleges breach of fiduciary duty, abuse of control, gross mismanagement, waste of assets, and unjust enrichment related to the Company’s press release dated October 27, 2004, in which the Company disclosed that its financial statements for certain prior periods should no longer be relied upon, and also provided updated financial guidance. All of these claims are asserted derivatively on behalf of the Company and seeks unspecified damages against those individuals.  Further, the Chairman of the Company’s Board of Directors received from a purported shareholder a demand letter (the “Demand Letter”) based on the same set of facts as the Purported Derivative Action.  The Demand Letter requests the Board to take certain action, but does not seek damages against the Company.  The Company has formed a special committee of the Board of Directors to evaluate the claims made in the Purported Derivative Action and the Demand Letter.

 

Digital Imaging Systems

 

On August 5, 2004, Digital Imaging Systems, Inc. filed suit against the Company in the United States District Court-Southern District of New York alleging, among other things, that a portion of the Company’s process for scanning and indexing images violates one of Digital Imaging Systems’ patents.  The Company has tendered this matter to one of its software/hardware vendors for indemnification, which such vendor has undertaken subject to pre-existing contractual conditions.  The suit demands unspecified damages.

 

Various ROI Copy Charge Matters

 

From time to time, various subsidiaries of the Company that perform release of information (“ROI”) services become defendants to putative class action lawsuits generally alleging that the charge for reproducing certain medical records is not in conformity with such plaintiffs’ reading of the applicable regulated charge. Such suits typically include multiple ROI companies and hospitals as defendants and demand reimbursement for prior charges as well as for prospective pricing adjustments. The Company is currently a party to several such suits in various stages of development.  One such suit originally styled McShane v. Recordex Acquisition Corp. & Sourcecorp, Incorporated (and now styled Liss & Marion, PC v. Recordex Acquisition Corp., & Sourcecorp, Inc.) filed February 10, 2003, in the Court of Common Pleas Philadelphia County, Pennsylvania, alleges among other things that the Company intentionally charges more for providing copies of medical records than is permitted under Pennsylvania law.  The complaint does not specify the amount of damages sought.  Plaintiff's counsel had at one time alleged damages were as high as $7 million without providing any real support for this amount; however, the Company believes that it will ultimately prevail in this matter, or if any liability is found, that the amount of damages, if any, would be substantially less than such alleged amount.  In September 2004, the court entered its order certifying a class in this matter and both the plaintiffs and the defendants have filed motions for summary judgment.

 

Spohr. et. al. v. F.Y.I. Incorporated, et. al.

 

In June 2000, the Company filed an action styled F.Y.I. Incorporated v. Spohr, et. al. in Dallas, Texas, in which we asserted claims for breach of contract, fraud, and negligent misrepresentation against the sellers of two related companies that we acquired in December 1998 (the “Texas Action”). The Texas Action was later removed to federal court and ultimately dismissed on jurisdictional grounds. We reasserted these claims in two actions that were later consolidated; one styled F.Y.I. Incorporated v. Spohr, et. al. in Superior Court of the State of California in the County of Sacramento, Case No. 01-AS-00721 (the “Sacramento Action”) and one styled Spohr, et. al. v. F.Y.I. Incorporated, et. al. in the Superior Court of the State of California in the County of San Francisco, Case No. 318703 (the “San Francisco Action”). In the consolidated action, we additionally filed claims against the sellers’ accountants and the two sellers filed claims against us; however, in February 2004, the judge in the Sacramento Action dismissed our claims against the sellers’ accountants. The sellers allege that our former subsidiary wrongfully failed and refused to execute and deliver a requested estoppel certificate, and that the failure to provide such estoppel certificate harmed the landlord in that they were allegedly denied favorable terms on a refinancing of the property and were allegedly prevented from completing a timely sale of the property. Sellers alleged damages of approximately $1.5 million. We asserted damages in excess of $8 million. On February 3, 2005, the parties settled this matter on mutually acceptable terms.

 

24



 

Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds

 

Items 2(a) and (b) are inapplicable.

 

(c) STOCK REPURCHASES

 

Period

 

(a) Total Number of
Shares Purchased

 

(b) Average
Price Paid per
Share

 

(c) Total Number of
Shares Purchased as
Part of Publicly
Announced Plans or
Programs

 

(d) Maximum Number of Shares (or
Approximate Dollar Value of Shares)
that May Yet Be Purchased Under
the Plans or Programs

 

 

 

 

 

 

 

 

 

 

 

Jan 1, 2005 – Jan 31, 2005

 

 

$

 

 

$

17,415,551

 

Feb 1, 2005 – Feb 28, 2005

 

 

$

 

 

$

17,415,551

 

Mar 1, 2005 – Mar 31, 2005

 

 

$

 

 

$

17,415,551

 

 

Item 6.    Exhibits

 

(a) Exhibits

 

Exhibit
Number

 

Description

3.1

 

Restated Certificate of Incorporation of SOURCECORP, Incorporated (Incorporated by reference to Exhibit 99.3 to Amendment No.1 to the Company’s Registration Statement on Form 8-A filed on February 15, 2002)

 

 

 

3.2

 

Amended and Restated By-Laws of SOURCECORP, Incorporated (Incorporated by reference to Exhibit 99.4 to Amendment No. 1 to the Company’s Registration Statement on Form 8-A filed on February 15, 2002)

 

 

 

4

 

Specimen certificate for the Common Stock, par value $.01 per share, of the Registrant. (Incorporated by reference to Exhibit 99.1 to Amendment No. 1 to the Company’s Registration Statement on Form 8-A filed on February 15, 2002)

 

 

 

31.1

 

Certification Pursuant to section 302 of Sarbanes-Oxley Act.

 

 

 

31.2

 

Certification Pursuant to section 302 of Sarbanes-Oxley Act.

 

 

 

32.1

 

Certification Pursuant to section 906 of Sarbanes-Oxley Act.

 

 

 

32.2

 

Certification Pursuant to section 906 of Sarbanes-Oxley Act.

 

25



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report on Form 10-Q to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

SOURCECORP, INCORPORATED

 

 

 

Date: May 12, 2005

By:

/s/ ED H. BOWMAN, JR.

 

 

Ed H. Bowman, Jr. Chief Executive
Officer and President

 

 

 

Date: May 12, 2005

By:

/s/ BARRY L. EDWARDS

 

 

Barry L. Edwards Executive Vice
President and Chief Financial Officer
(Principal Financial and Accounting
Officer)

 

26



 

INDEX TO EXHIBITS

 

Exhibit
Number

 

Description

3.1

 

Restated Certificate of Incorporation of SOURCECORP, Incorporated (Incorporated by reference to Exhibit 99.3 to Amendment No.1 to the Company’s Registration Statement on Form 8-A filed on February 15, 2002)

 

 

 

3.2

 

Amended and Restated By-Laws of SOURCECORP, Incorporated (Incorporated by reference to Exhibit 99.4 to Amendment No. 1 to the Company’s Registration Statement on Form 8-A filed on February 15, 2002)

 

 

 

4

 

Specimen certificate for the Common Stock, par value $.01 per share, of the Registrant. (Incorporated by reference to Exhibit 99.1 to Amendment No. 1 to the Company’s Registration Statement on Form 8-A filed on February 15, 2002)

 

 

 

31.1

 

Certification Pursuant to section 302 of Sarbanes-Oxley Act.

 

 

 

31.2

 

Certification Pursuant to section 302 of Sarbanes-Oxley Act.

 

 

 

32.1

 

Certification Pursuant to section 906 of Sarbanes-Oxley Act.

 

 

 

32.2

 

Certification Pursuant to section 906 of Sarbanes-Oxley Act.

 

27